A 72-year-old man is brought to the emergency department from a skilled nursing facility d… — USMLE Step 3

A $72$ -year-old man is brought to the emergency department from a skilled nursing facility due to altered mental status, fever, and purulent sputum production over the past $24$ hours. His medical history is significant for severe chronic obstructive pulmonary disease (COPD), type $2$ diabetes mellitus, and chronic kidney disease stage $3$ . Three weeks ago, he was treated with a $10$ -day course of oral levofloxacin for a COPD exacerbation.

On arrival, his temperature is $39.1^\circ\text{C}$ ( $102.4^\circ\text{F}$ ), blood pressure is $82/50\text{ mm Hg}$ , pulse is $122/\text{min}$ , and respirations are $28/\text{min}$ . Oxygen saturation is $86\%$ on room air.

Physical examination reveals coarse crackles in the right lung base and decreased breath sounds globally.

Laboratory studies show a leukocyte count of $18,500/\text{mm}^3$ with $15\%$ bands, blood urea nitrogen of $42\text{ mg/dL}$ , and a serum creatinine of $2.1\text{ mg/dL}$ (baseline $1.4\text{ mg/dL}$ ).

Chest radiograph demonstrates a dense consolidation in the right lower lobe.

After securing the airway and administering a rapid intravenous fluid bolus, vasopressor therapy is initiated.

Which of the following antimicrobial agents should be included in this patient's empiric regimen? (Select all that apply)

VancomycinCevap
CefepimeCevap
C
Daptomycin
D
Ceftriaxone
E
Ciprofloxacin

Cevap

The correct agents to include are Vancomycin and Cefepime.

The patient presents with septic shock secondary to pneumonia. Because he resides in a skilled nursing facility and received a broad-spectrum antibiotic (levofloxacin) within the past 90 days, he is at exceptionally high risk for infection with Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Current infectious disease guidelines mandate that critically ill patients with these risk factors receive aggressive, broad-spectrum empiric therapy covering both pathogens. Vancomycin provides the necessary MRSA coverage, while cefepime, a fourth-generation cephalosporin, provides excellent antipseudomonal coverage. Together, these two agents form a robust empiric regimen while pending culture and susceptibility data.

Adım Adım Çözüm

Assess the clinical severity and establish the primary diagnosis.

The patient is presenting with healthcare-associated pneumonia complicated by septic shock, as evidenced by his source of infection, hypotension, and requirement for vasopressor support.

Identifying the severity of illness dictates the urgency, route, and necessary breadth of empiric antimicrobial therapy.

Identify patient-specific risk factors for multidrug-resistant organisms.

The patient resides in a skilled nursing facility and received a course of a broad-spectrum antibiotic (levofloxacin) just 3 weeks ago.

Recent systemic antibiotic use (within the past 90 days) is the most significant predictor for infection with Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.

Select appropriate empiric antimicrobial agents targeting the suspected resistant pathogens.

The regimen must include an anti-MRSA agent (vancomycin) and an antipseudomonal beta-lactam (cefepime).

Inadequate empiric coverage for MRSA or Pseudomonas in a critically ill patient with septic shock dramatically increases morbidity and mortality.

Exclude contraindicated or inappropriate antibiotics from the potential choices.

Daptomycin is excluded due to pulmonary surfactant inactivation. Ceftriaxone is excluded because it lacks pseudomonal coverage. Ciprofloxacin is excluded due to the high risk of resistance following recent levofloxacin use.

Ensures the selected regimen is both clinically safe and maximally effective based on pharmacodynamics and the patient's pharmacological history.

Anahtar Kavram

Empiric antimicrobial therapy for severe pneumonia with risk factors for multidrug-resistant organisms.

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru